Newly Discovered Limonoid DHL-11 from Munronia henryi Targets IMPDH2 to Combat Triple-Negative Breast Cancer
A groundbreaking study recently published in the prestigious journal Acta Pharmaceutica Sinica B has unveiled a promising new therapeutic candidate, DHL-11, a novel prieurianin-type limonoid isolated from the plant Munronia henryi,...
Read moreDetails























